Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00907790 · ClinicalTrials.gov registry record · NA

Nursing Management of Irritable Bowel Syndrome (IBS) 2008

A NA study of Irritable Bowel Syndrome, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
92
Enrollment target
1
Study location

NCT00907790 is a NA study of Irritable Bowel Syndrome that has completed, run by University of Washington. The registered enrollment target is 92 participants, below the 142-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00907790, a NA study of Irritable Bowel Syndrome, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
92 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is test the efficacy of a comprehensive self-management therapy to decrease abdominal pain/discomfort and improve quality of life in patients with irritable bowel syndrome (IBS) compared to IBS patients receiving their usual care.

Conditions Studied

Interventions

  • BEHAVIORAL Usual Care (Control Group)
  • BEHAVIORAL Comprehensive Self-Management (CSM)

Study Locations (1)

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 92 participants
Start Date 2009-03
Est. Completion 2013-01
Phase NA

Sponsor

University of Washington

1,048 total trials

What the Registry Record Tells You About NCT00907790

The ClinicalTrials.gov registry entry for NCT00907790 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 142-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (35% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Irritable Bowel Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Usual Care (Control Group) is the first listed.

NCT00907790 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT00907790 about?

NCT00907790 is a clinical study titled "Nursing Management of Irritable Bowel Syndrome (IBS) 2008". The aim of this study is test the efficacy of a comprehensive self-management therapy to decrease abdominal pain/discomfort and improve quality of life in patients with irritable bowel syndrome (IBS) compared to IBS patients receiving their usual care.

What is the current status of trial NCT00907790?

This trial is currently completed. It is a NA study. The enrollment target is 92 participants. The study started on 2009-03. Estimated completion is 2013-01.

What conditions does trial NCT00907790 study?

This clinical trial studies the following conditions: Irritable Bowel Syndrome.

What interventions are being tested in trial NCT00907790?

The interventions under investigation include: Usual Care (Control Group) (BEHAVIORAL), Comprehensive Self-Management (CSM) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00907790?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00907790 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Irritable Bowel Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.